Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ifrah

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Leukemia|January 1, 1992
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AMLJ L Harousseau, B Pignon, P Dufour, et al.
Arthritis Care & Research|May 18, 2011
Systemic and immune manifestations in myelodysplasia: a multicenter retrospective studyA de Hollanda, A Beucher, D Henrion, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
Leukemia|December 13, 2005
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110delta mutationsP Cornillet-Lefebvre, W Cuccuini, V Bardet, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Blood|June 1, 1992
Double-intensive therapy in high-risk multiple myelomaJ L Harousseau, N Milpied, J P Laporte, et al.
British Journal of Haematology|November 5, 1997
Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow TransplantationP Guardiola, H Esperou, D Cazals-Hatem, et al.
Annales De Biologie Clinique|December 7, 2005
[Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies]J Gérard, F Dubois-Galopin, M Gardembas-Pain, et al.
Presse Medicale (Paris, France : 1983)|November 25, 1989
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol]B Desablens, J M Tourani, P Casassus, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Leukemia|January 1, 1992
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AMLJ L Harousseau, B Pignon, P Dufour, et al.
Arthritis Care & Research|May 18, 2011
Systemic and immune manifestations in myelodysplasia: a multicenter retrospective studyA de Hollanda, A Beucher, D Henrion, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
Leukemia|December 13, 2005
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110delta mutationsP Cornillet-Lefebvre, W Cuccuini, V Bardet, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Blood|June 1, 1992
Double-intensive therapy in high-risk multiple myelomaJ L Harousseau, N Milpied, J P Laporte, et al.
British Journal of Haematology|November 5, 1997
Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow TransplantationP Guardiola, H Esperou, D Cazals-Hatem, et al.
Annales De Biologie Clinique|December 7, 2005
[Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies]J Gérard, F Dubois-Galopin, M Gardembas-Pain, et al.
Presse Medicale (Paris, France : 1983)|November 25, 1989
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol]B Desablens, J M Tourani, P Casassus, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Pageof 13